Tvardi Therapeutics

TVRDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$23.266 M

$1.87 +1.08%

Close of 7 Aug 2026

Revenue

$7.14M

#3237 by revenue

Earnings

-$18.2M

Loss-making

Shares outstanding

9,381,344

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#387LongeveronLGVN$24.2M
#388TherapeuticsMDTXMD$24.0M
#389Tvardi TherapeuticsTVRD$23.3M
#390Quantum BiopharmaQNTM$22.1M
#391Allarity TherapeuticsALLR$21.5M

Where these numbers come from

Share counts and financials for Tvardi Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.